Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of 806,433. The enterprise value is -1.56 million.
| Market Cap | 806,433 |
| Enterprise Value | -1.56M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 10.93 million shares outstanding. The number of shares has increased by 841.08% in one year.
| Current Share Class | 10.93M |
| Shares Outstanding | 10.93M |
| Shares Change (YoY) | +841.08% |
| Shares Change (QoQ) | +1,935.72% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 1.74% |
| Float | 10.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.21 |
| P/TBV Ratio | 0.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.09 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.75, with a Debt / Equity ratio of 0.14.
| Current Ratio | 6.75 |
| Quick Ratio | 4.90 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.18 |
Financial Efficiency
Return on equity (ROE) is -288.06% and return on invested capital (ROIC) is -159.30%.
| Return on Equity (ROE) | -288.06% |
| Return on Assets (ROA) | -86.54% |
| Return on Invested Capital (ROIC) | -159.30% |
| Return on Capital Employed (ROCE) | -286.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -747,477 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.85% in the last 52 weeks. The beta is 1.55, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | -99.85% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 16.14 |
| Relative Strength Index (RSI) | 33.04 |
| Average Volume (20 Days) | 136,703 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.44M |
| Pretax Income | -16.44M |
| Net Income | -16.44M |
| EBITDA | -15.44M |
| EBIT | -15.44M |
| Earnings Per Share (EPS) | -20.38 |
Balance Sheet
The company has 4.59 million in cash and 526,178 in debt, giving a net cash position of 4.06 million or 0.37 per share.
| Cash & Cash Equivalents | 4.59M |
| Total Debt | 526,178 |
| Net Cash | 4.06M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 3.90M |
| Book Value Per Share | 0.23 |
| Working Capital | 5.38M |
Cash Flow
| Operating Cash Flow | -15.72M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -841.08% |
| Shareholder Yield | n/a |
| Earnings Yield | -2,039.17% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | Mar 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |